Skip to main content
. 2020 Feb 5;11(2):164. doi: 10.3390/genes11020164

Table 1.

Baseline clinical characteristics of all the study subjects.

Parameters Controls
(n = 54)
Patients with CAD
(n = 78)
Patients with NCA
(n = 15)
p-Value p-Value
Age (years) 53.1 ± 11.5 58.7 ± 9.4 60.4 ± 9.6 0.0028 * 0.0286 *
Gender (Male %) 64.8 62.8 53.3 0.8166 0.4244
SBP (mmHg) 122.7 ± 8.4 132.9 ± 17.7 130.9 ± 15.4 0.0003 * 0.0112 *
DBP (mmHg) 79.5 ± 6.3 80.3 ± 14.2 80.33 ± 22.3 0.7192 0.8234
BMI (Kg/m2) 24.87 ± 5.4 25.76 ± 3.2 24.22 ± 5.7 0.2804 0.1879
Obesity (%) 12.96 42.3 46.7 0.0002 * 0.0036 *
Diabetes mellitus (%) 0 28.2 26.7 - -
Hypertension (%) 0 57.7 53.3 - -
LDL-C (mg/dL) 102.4 ± 34.7 93.15 ± 24.9 89.56 ± 20.55 0.1029 0.2871
HDL-C (mg/dL) 41.54 ± 13.3 41.91 ± 11.1 44.67 ± 10.55 0.8727 0.5076
TC (mg/dL) 177.74 ± 42.03 176.76 ± 34.11 157.47 ± 52.45 0.8908 0.0964

Data are means ± SD and mean percent values. Mean values of the different parameters in the study subjects were analyzed by chi-square and Student’s t-test of significance as appropriate; p-value —Patients with CAD vs. Controls. p-value —Patients with NCA vs. Controls. * p < 0.05 is considered to be significant. Age (p-value—0.0028 and 0.0286 ), SBP (p-value—0.0003 and 0.0112 ) and Obesity (p-value—0.0002 and 0.0036 ) were found to be significantly different between the groups.